Caffeine: Mechanism of Alertness and Cognitive Enhancement

Pharmacology

Caffeine (1,3,7-trimethylxanthine) is a non-selective adenosine receptor antagonist (A₁, A₂A).

Mechanism

  1. Adenosine accumulates during wakefulness → binds A₁/A₂A → inhibits acetylcholine, dopamine, norepinephrine release → sleep pressure.
  2. Caffeine blocks receptors → disinhibits arousal neurotransmitters.
  3. Secondary: ↑cAMP (PDE inhibition), ↑Ca²⁺ release, mild dopamine D2 affinity.

Effects

  • Alertness, vigilance, reaction time (50–300 mg).
  • Working memory, executive function (moderate dose).
  • Mood elevation (low-moderate); anxiety/jitter (high dose/sensitive).
  • Ergogenic: ↑time to exhaustion, ↓RPE.

Practical Limits

  • Half-life 3–7 hrs (CYP1A2 polymorphism; smoking halves, OCP doubles).
  • Ceiling effect ~400 mg/day; >600 mg → toxicity (tachycardia, insomnia, GI).
  • Dependence: withdrawal headache, fatigue at 12–24h abstinence.

Chronic Fatigue Syndrome - Related Articles